Key result
Complete preservation of the mitral valve apparatus during MVR showed no significant difference in 30-day mortality compared to partial preservation.
Why the study?
Does complete preservation of the mitral valve apparatus improve clinical outcomes compared to partial preservation in patients undergoing mitral valve replacement?
Meta-Analysis (n=1,535)
Does complete preservation of the mitral valve apparatus improve clinical outcomes compared to partial preservation in patients undergoing mitral valve replacement?
Answers are grounded in this paper and cite their sources.
Complete preservation of the mitral valve apparatus during mitral valve replacement does not appear to offer superior clinical outcomes compared to partial preservation.
OBJECTIVES: To determine if there is any real difference between complete preservation (CP) and partial preservation (PP) of the mitral valve apparatus during mitral valve replacement (MVR) in terms of hard outcomes. METHODS: MEDLINE, EMBASE, CENTRAL/CCTR, SciELO, LILACS, Google Scholar and reference lists of relevant articles were searched for clinical studies that compared outcomes [30-day mortality, postoperative low cardiac output syndrome (LCOS), 5-year mortality or left ventricle ejection fraction (LVEF) before and after surgery] between MVR-CP vs MVR-PP during MVR until July 2012. The principal summary measures were odds ratios (ORs) with 95% confidence interval (CI)--for categorical variables (30-day mortality, postoperative LCOS, 5-year mortality); difference means and standard error (SE)--for continuous variables (LVEF before and after surgery) and P values (that will be considered statistically significant when <0.05). The ORs were combined across studies using DerSimonian-Laird random effects weighted model. The same procedure was executed for continuous variables, taking into consideration the difference in means. RESULTS: Eight studies (2 randomized and 6 non-randomized) were identified and included a total of 1535 patients (597 for MVR-CP and 938 for MVR-PP). There was no significant difference between MVR-CP or MVR-PP groups in the risk for 30-day mortality (OR 0.870; 95% CI 0.50-1.52; P = 0.63) or postoperative LCOS (OR 0.35; 95% CI 0.11-1.08 and P = 0.07) or 5-year mortality (OR 0.70; 95% CI 0.43-1.14; P = 0.15). Taking into consideration LVEF, neither MVR-CP nor MVR-CP demonstrated a statistically significant improvement in LVEF before and after surgery, and both strategies were not different from each other. No publication bias was observed. CONCLUSIONS: We found evidence that argues against any superiority between both techniques of preservation (complete or partial) of mitral valve apparatus during MVR.
No takes yet. Share an insight, caveat, or question.
Sá et al. (2013) conducted a meta-analysis in Mitral valve replacement (n=1,535). Complete preservation of mitral valve apparatus vs. Partial preservation of mitral valve apparatus was evaluated on 30-day mortality (OR 0.870, 95% CI 0.50-1.52, p=0.63). Complete preservation of the mitral valve apparatus during MVR showed no significant difference in 30-day mortality compared to partial preservation.
Synapse has enriched 10 related papers. Consider them for comparative context: